Results
3033
Companies which are more than 50% undervalued based on analyst price target.
3033 companies
Premier Health of America
Market Cap: CA$1.7m
Engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada.
PHA
CA$0.03
7D
-14.3%
1Y
-81.8%
PHAXIAM Therapeutics
Market Cap: €1.0m
A clinical-stage biopharmaceutical company, focuses on developing bacteriophage-based therapies for severe resistance infections in France.
PHXM
€0.10
7D
0%
1Y
-94.0%
Bio-Path Holdings
Market Cap: US$996.9k
Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.
BPTH
US$0.11
7D
4.2%
1Y
-88.6%
Sileon
Market Cap: SEK 9.2m
A fintech company, provides SaaS platform that supports businesses in Sweden.
SILEON
SEK 2.80
7D
-3.4%
1Y
-88.1%
Zapp Electric Vehicles Group
Market Cap: US$635.2k
Designs, manufactures, and sells electric vehicles under the Zapp brand.
ZAPP.F
US$0.07
7D
-29.8%
1Y
-98.0%
ConnectM Technology Solutions
Market Cap: US$213.9k
Provides a digital platform for the electrification and decarbonization of homeowners in the United States and India.
CNTM
US$0.003
7D
0%
1Y
-99.7%
G Medical Innovations Holdings
Market Cap: US$26.4k
An early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel.
GMVD.F
US$0.0001
7D
0%
1Y
9,900.0%
Formation Minerals
Market Cap: US$20.0k
Acquires and manages oil and gas minerals and royalties in the United States.
FOMI
US$0.0002
7D
-99.0%
1Y
-99.4%
Medicine Man Technologies
Market Cap: US$85.0
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.
SHWZ
US$0.0022
7D
69.2%
1Y
-99.3%